Yvonne

#MyelomaWarrior

[Yvonne @YaksicY]

@marklewismd Dr. Lewis You rock! Thank you for your posts!

[Yvonne @YaksicY]

@VincentRK @bdermanmd Dr. Rajkumar - thank you for all of your very informative posts. You really help to keep me updated on the ever changing treatments for MM. I read of an interesting trial happening at MUSC Hollings Cancer Center.

[Yvonne @YaksicY]

@JackMAiello @JoshuaRichterMD @MMBaljevicMD @LLSusa Thanks Jack, Your MM journey is always inspiring. We are showing your very informative video at our meeting next week.

[Urvi Shah @UrviShahMD]

Dietary research in blood cancers is an unmet need. Excited that #ASH22 has a special scientific symposium dedicated to Building Dietary Evidence for Hematologic Malignancies this year! Hope you can attend @ASH_hematology @MSKCancerCenter #diet #mmsm #lymsm #leusm #mdssm #mpnsm

[Yvonne @YaksicY]

The smiles ..the hair…and dedication to hematology!

[Ajay Major, MD, MBA @majorajay]

The most important trial at #ASH22: NEUTRODIET, a randomized multicenter trial of 'neutropenic diet' vs normal diet after auto/alloSCT. No differences in infections, aGHVD or hospital days between arms. Less weight loss & better patient satisfaction in normal diet arm! #tcellrx

[Yvonne @YaksicY]

Love this group! Thank you! #IMFASH22

[Robin Tuohy @IMFsupport]

In person #ASH22 ⁦@IMFmyeloma⁩ support group leader team ⁦@DianeHunterMM⁩ ⁦@IMFsupport⁩ ⁦@IMFmikeMYELOMA⁩ ⁦@LindaMyeloma⁩ ⁦@MMyelomaLiving⁩ ⁦@IMFnurseMyeloma⁩ #IMFASH22 #myeloma We also have a team of 7 leaders virtually attending too!

[Teresa Miceli. ❤️&☮️4🌎 @IMFnurseMyeloma]

Defining HRMM, Dr. Tim Schmidt: #ASH22 #mmsm #myeloma

[Teresa Miceli. ❤️&☮️4🌎 @IMFnurseMyeloma]

Sustained MRD- is better than no MRD-, but concern for early conversion MRD- that is not sustained, and delayed MRD- may be better than early MRD-. Also need to use same sensitivity of testing. More info is needed to help guide practice. @Taxkourel #ASH22 #mmsm #myeloma

[Vincent Rajkumar @VincentRK]

Real world data from Canada for transplant eligible patients with myeloma shows median overall survival of 10 years:

13 years for std risk
7.5 years for high risk.

This is real progress. #ASH22 #JulieCote @HiraSMian https://t.co/zgsaaxtT6j

[Sheri Baker @blondie1746]

@Daw6Jessie @IMFmyeloma Don't save the best for last. Hit it hard up front.

[Yvonne @YaksicY]

Thank you John! #IMFASH22

[Robin Tuohy @IMFsupport]

This group of #myeloma support group patients & support group leaders are ready to learn and share from the @IMFmyeloma Satellite Symposium focusing on SMM, FrontLine, First Relapse, Relapse/Refractory, Individualizing Therapy, BCMA, MM Algorithms #ASH22 #IMFASH22

[Vincent Rajkumar @VincentRK]

At #ASH22 my colleague @myelomaMD will present the initial results of the ASCENT trial, aka the 2nd Cure trial to test the hypothesis whether myeloma can be cured if highly active combination therapy is given early at the smoldering myeloma stage. https://t.co/9fvVoPvwBM

[Robin Tuohy @IMFsupport]

This blog is powerful and inspiring in so many ways! #ASH22 #IMFASH22 #myeloma @IMFmyeloma @MidAtlanticMSG

[Yvonne @YaksicY]

Thanks to the IMF and my fellow support group leaders for their hard work in bringing us this very important information. I look forward to reading your blog Sheri. #IMFASH22

[Sheri Baker @blondie1746]

ASH begins tomorrow with the Friday symposium. The IMF and the Support Group Leader team is ready to go. Some in person, some virtually. We look forward to learning and sharing with our support groups about the amazing research taking place. #ASH22 @IMFmyeloma #IMFASH22 #mmsm

[Yvonne @YaksicY]

@MMyelomaLiving Thank you - I look forward to reading your blog!

[International Myeloma Foundation @IMFmyeloma]

The IMF once again brings Support Group Leaders to the American Society of Hematology annual meeting to blog and tweet live from the event. Gear up with what's to come with this overview blog from @JackMAiello
https://t.co/FVdmirJihQ

#ASH2022 #IMFASH22

[Coach Bonnie @CoachBon]

So welcome this research!

[Robin Tuohy @IMFsupport]

Attn #IMFASH22 Support Group Leader Team from @VincentRK #ASH22 #myeloma #mmsm